Trial Profile
A Multicenter, Retrospective study to evaluate the safety and efficacy of Ixekizumab in patients with moderate to severe Plaque psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jul 2019
Price :
$35
*
At a glance
- Drugs Ixekizumab (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- 09 May 2018 New trial record